Home > Category > Signaling Pathways > GPCR & G Protein > Prostaglandin Receptor > NS-304 (Selexipag; ACT-293987)

NS-304 (Selexipag; ACT-293987)

ChemLeader 98+%

Catalog No：CL2526 CAS No.：475086-01-2 MDLNo： Formula：C26H32N4O4S MW：496.62

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	NS-304 (Selexipag; ACT-293987)
CAS	475086-01-2
Formula	C26H32N4O4S
MW	496.62
Appearance	White to yellow powder

Product details

Selexipag, also known as ACT-293987 and NS-304, is a a first-in-class orally available selective non-prostanoid IP receptor agonist, which is currently in development by Actelion as a treatment of pulmonary arterial hypertension. Selexipag and its active metabolite, ACT-333679, are agonists at the prostacyclin receptor, which leads to vasodilation in the pulmonary circulation.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CL2526

NS-304 (Selexipag; ACT-293987)

475086-01-2 98+%